Selected article for: "crp concentration and normal crp concentration"
Author: Huijie Bian; Zhao-Hui Zheng; Ding Wei; Zheng Zhang; Wen-Zhen Kang; Chun-Qiu Hao; Ke Dong; Wen Kang; Jie-Lai Xia; Jin-Lin Miao; Rong-Hua Xie; Bin Wang; Xiu-Xuan Sun; Xiang-Min Yang; Peng Lin; Jie-Jie Geng; Ke Wang; Hong-Yong Cui; Kui Zhang; Xiao-Chun Chen; Hao Tang; Hong Du; Na Yao; Shuang-Shuang Liu; Lin-Na Liu; Zhe Zhang; Zhao-Wei Gao; Gang Nan; Qing-Yi Wang; Jian-Qi Lian; Zhi-Nan Chen; Ping Zhu
Title: Meplazumab treats COVID-19 pneumonia: an open-labelled, concurrent controlled add-on clinical trial
  • Document date: 2020_3_24
    • ID: 6g34qwer_32
    Snippet: We also measured the concentration of CRP, as a predictors of COVID-19 severity. 19 As shown in figure 6B , from day 3 to day 28, the percentages of patients with a normal CRP concentration (≤5mg/L) were increased from 52.9% (9/17) to 82.4% (14/17), indicating significant increases compared to baseline (all p<0.05 at days 3, 7, 14, 21, and 28). In control group, the significant increases were observed at day 14, and day 21 compared to baseline......
    Document: We also measured the concentration of CRP, as a predictors of COVID-19 severity. 19 As shown in figure 6B , from day 3 to day 28, the percentages of patients with a normal CRP concentration (≤5mg/L) were increased from 52.9% (9/17) to 82.4% (14/17), indicating significant increases compared to baseline (all p<0.05 at days 3, 7, 14, 21, and 28). In control group, the significant increases were observed at day 14, and day 21 compared to baseline. The data suggests that meplazumab exhibited an effect on the control of virus-induced acute inflammation at early management.

    Search related documents:
    Co phrase search for related documents
    • acute inflammation and CRP concentration: 1
    • acute inflammation and early management: 1
    • acute inflammation and severity predictor: 1
    • acute inflammation and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9
    • acute inflammation and virus induce: 1, 2, 3
    • acute inflammation and virus induce acute inflammation: 1, 2, 3
    • baseline compare and control group: 1, 2, 3, 4, 5, 6
    • baseline compare and significant increase: 1, 2, 3
    • control group and CRP concentration: 1, 2, 3, 4, 5, 6
    • control group and early management: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • control group and normal crp concentration: 1, 2
    • control group and severity predictor: 1, 2, 3, 4, 5, 6
    • control group and significant increase: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
    • control group and virus induce: 1, 2, 3, 4, 5
    • CRP concentration and normal crp concentration: 1, 2, 3, 4, 5
    • early management and severity predictor: 1, 2, 3
    • early management and significant increase: 1, 2, 3, 4, 5, 6, 7, 8
    • severity predictor and significant increase: 1, 2